MRNA injection aims to strengthen bladder control in women
NCT ID NCT06247241
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was testing a new drug called VMB-100, which is an mRNA that tells muscle cells to produce a protein (IGF-1) to help repair the urethra sphincter. The goal was to improve muscle function and reduce urine leakage in women with moderate stress urinary incontinence. The study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE STRESS URINARY INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow drug strengthen pelvic muscles to curb incontinence?
- Can ancient qigong movements fortify pelvic health after childbirth?
- Can a single dose of muscle cells hold up for years against stubborn incontinence?
- 6-Year study examines whether a simple strip can keep stress incontinence under control
- New gadget aims to treat leaky bladder from home
- Tiny trial on preventive bladder sling halted early — no clear answers